Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  April 2014  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
282930 

Friends
    Links


    Entry 1 of 2990
    Last Page | Next Page
    6/8/2009 - Memgen Reports Positive Results For ISF35 In High-Risk Chronic Lymphocytic Leukemia
    Posted in Medical News

    Memgen announced that the ongoing Phase Ib study of its cancer immune therapy, ISF35, has produced crashing results, including a perfect
    quiescence in the trial's first patient who had 17p deleted chronic lymphocytic leukemia (CLL). The study, which is co-sponsored by the Leukemia & Lymphoma Society, assesses the ability of ISF35 to re-sensitize refractory and/or 17p deleted CLL to chemotherapy.

    More: - The rest...

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb